Merck & Co.
213 E Grand Avenue, South San Francisco, CA
33 Avenue Louis Pasteur, Boston, MA
320 Bent St, Cambridge, MA 02141
United States
4224 articles about Merck & Co.
-
National Institute for Clinical Excellence (NICE) Backs Merck & Co., Inc. Hepatitis C Drug Victrelis
3/9/2012
-
Vertex Pharmaceuticals (MA), Merck & Co., Inc. Hepatitis Drugs Work in HIV Patients
3/8/2012
-
Merck & Co., Inc. Release: Results from Investigational Studies with VICTRELIS™ (boceprevir) Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1
3/7/2012
-
Merck & Co., Inc.: FDA Won't OK Its Combo Cholesterol Drug Now
3/6/2012
-
Merck & Co., Inc. Confirms 2012 Full-Year Guidance
3/6/2012
-
Abbott Laboratories and Merck & Co., Inc. Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy
3/6/2012
-
Merck & Co., Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
3/5/2012
-
Merck & Co., Inc. Reveals Positive Results From Phase III Study of AIT for Ragweed Pollen
3/5/2012
-
Merck & Co., Inc. Warned by FDA on Failure to Study Januvia for Side Effects
3/1/2012
-
Merck & Co., Inc. Legal Settlement to Bolster Clinical Data Reporting
3/1/2012
-
Merck & Co., Inc. Announces Second-Quarter 2012 Dividend
2/29/2012
-
Merck & Co., Inc. to Present at the 2012 Citi Global Healthcare Conference
2/28/2012
-
Protein Sciences Corporation Licenses Proprietary expresSF+® Insect Cell Technology to Merck & Co., Inc.
2/22/2012
-
Previous Merck & Co., Inc. and Bayer Pharmaceuticals Corporation (CT) Executive Accepts Full Time Role and Company Adds More Experience to Fuse Science Management Team
2/16/2012
-
Merck & Co., Inc. Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil
2/15/2012
-
FDA Approves Merck & Co., Inc. Drug for Glaucoma
2/15/2012
-
Merck & Co., Inc. to Present at the Leerink Swann and Company 2012 Global Healthcare Conference
2/14/2012
-
Merck & Co., Inc. Open to More Indian JVs
2/10/2012
-
FDA, Merck & Co., Inc. Warn Against Using Victrelis With Some HIV Drugs
2/10/2012
-
Thomas E. Shenk to Retire from Merck & Co., Inc.'s Board of Directors
2/9/2012